Fritextsökning
Innehållstyper
-
Studie: Tidig blodplasma minskar risk för allvarlig covid-19
Äldre personer med covid-19 som får blodplasma från tillfrisknade patienter löper minskad risk att bli allvarligt sjuka, enligt en ny studie. Men bara om de får...
-
Seminar program Biotech Forum
Here is the entire seminar program at Biotech Forum September 28-29th
-
Crafoord Prize to an American and two Japanese
Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
Planen: Så ska Stockholm bli en ledande life science-stad
Stockholm vill bli värdstad för en av de största internationella kongresserna om medicinteknik. Planen är en del i ambitionen att bli en av de mest framstående ...
-
New Nordic biotech company
The Swiss biotech company Tillots Pharma opens a office in Stockholm, which will be run under private management.
-
Cate Poulsen, Qiagen
Why are you going to Scanlab and Biotech Forum?
-
An industry emerging from crisis
"Scanlab is normally indicative of the status of investment incentives in the laboratory industry "
-
"Vår nanoteknik skapar extremt små partiklar"
Läkemedel som finfördelas till nanopartiklar kan ge bättre effekt.
-
Ideon - Sweden's oldest science park
Old is not synonymous with boring. Swedens oldest science park Ideon still manages to attract young companies with big ideas. The recipe for success? To continu...
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Vaccinforskaren: ”Kanonbra med flera vacciner”
Professor Matti Sällberg välkomnar att EU skrivit flera avtal om covid-19-vaccin.
-
Tre gånger så många har dött av covid-19 enligt ny studie
18 miljoner människor – så många kan ha dött under pandemin, säger forskare bakom ny stor internationell studie. Det är tredubbelt fler än vad som tidigare rapp...
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recognized as good ones: in 2008, he was awarded the Eric K. Fernström Foundation's Prize for young...
-
Index tar in dansk toppchef i styrelsen
Lundbecks Stig Løkke Pedersen blir ledamot i Stockholmsbolaget.
-
Studie: Antikroppar minskar inte inom fyra månader efter covid-19 infektion
Antikroppsnivåerna är högre hos äldre personer som hade återhämtat sig från covid-19.
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Pfizers covidvaccin bedöms som lovande men mer data behövs
De resultat som Pfizer presenterat för sitt coronavaccin pekar åt rätt håll, anser Gunilla Karlsson Hedestam, professor i immunologi vid Karolinska institutet.
-
Next generation sequencer in an accessible format
The GS Junior System is a new benchtop-sized next generation sequencing platform.
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Peab-grundarens stiftelse ger 22 miljoner till life science
Nya behandlingmetoder av cancer, blodbrist och herpesvirus, nya tekniker för kartläggning av gener och upptäckt av sårinfektioner och ett växtbaserat järntillsk...
-
Academia - a strong player on the lab market
While the industry was short of money during the financial crisis, government incentives were in full swing in Sweden during 2009. - Our sales to academia incre...
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.